47 Visceral fat accumulation in patients with obesity causes a number of changes (oxidative stress, activation of the RAAS and gut dysbiosis), resulting in insulin resistance, increased vascular stiffness, T2D, dyslipidaemia, hypertension, coronary atherosclerosis and, ultimately, HFpEF
At Mason Park Medical Clinic in Katy, TX, we make seasonal flu prevention straightforward and accessible for the entire community
Key Study Findings During the 36-week, open label tirzepatide treatment period, mean weight loss was 21%, or approximately 22.5 kg/50 pounds
It was first FDA-approved in 2022, also as a treatment for controlling blood sugar in people with type 2 diabetes